
Chinese scientists develop low-cost cell therapy for cancer, asthma and other illnesses
Advertisement
This new method is much easier to programme than the conventional approach and is available at a fraction of the cost, according to experts in the field.
The treatment, known as CAR-T, is a type of immunotherapy that has taken off in recent years and has also shown promise in treating other conditions such as
asthma and autoimmune diseases. However, these cell therapies are difficult to produce and deliver to patients, and
they are expensive
Now, a group of Chinese
medical experts has proposed a solution to these drawbacks using gene therapy tools. They reported that they had managed to produce anti-cancer cells directly inside the human body and, for the first time, had used them to treat four patients with multiple myeloma – the second most common form of blood cancer.
Currently, the cost of a single treatment is estimated to exceed one million yuan (US$139,200).
Advertisement
The study, led by researchers from the Institute of Haematology at Huazhong University of Science and Technology's Tongji Medical College Union Hospital in Wuhan, was published in the peer-reviewed journal The Lancet earlier this month.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


South China Morning Post
40 minutes ago
- South China Morning Post
China courier puts sick daughter in delivery box while working as she can't afford childcare
A Chinese mother who delivered food with her 4-year-old sick daughter inside a meal-carrying box so that she could look after her has received sympathy online. The woman, surnamed Zhu, and her child were caught on camera by an online influencer in eastern China's Anhui province. The 25-year-old delivered food on an electric bicycle in the summer heat while carrying her daughter in the box attached to the vehicle. The girl has a vein-detained needle on one hand and a chemo port on her chest. Zhu feeds her four-year-old daughter between deliveries as she sits in the courier box. Photo: Douyin Her mother, surnamed Zhu, said the girl, Nuoxi, was diagnosed with a tumour two years ago.


South China Morning Post
14 hours ago
- South China Morning Post
US Earth imaging satellite fleet is creating ‘low-cost orbital landmines', China team says
A team of Chinese researchers has criticised the world's largest Earth-imaging satellite fleet, describing the shoebox-sized spacecraft as 'low-cost orbital landmines' that threaten the safety of space operations. Using a self-developed tracking platform, software scientists at the Chinese Academy of Sciences analysed the Dove constellation – which has launched hundreds of CubeSats since 2013 to provide daily, medium-resolution imagery of the Earth's surface – according to the team's article posted on Chinese social media on July 21. The Chinese team said the thruster-less satellites operated by San Francisco-based Planet Labs, posed a growing threat to space safety. They found that by early July more than 80 per cent of the 662 Dove satellites had deorbited, raising concerns about uncontrolled re-entry and potential collisions. They also noted that more than 100 Doves listed in public databases, including the US Space Force's tracking website, were assigned 'incorrect or fabricated' identification codes and lacked orbital data. 01:19 SpaceX Starship explodes during routine pre-launch ground test SpaceX Starship explodes during routine pre-launch ground test 'The Dove constellation has reshaped the commercial Earth observation industry with its low-cost, high-frequency observation model,' the researchers wrote. 'However, it may be turning valuable low Earth orbits into a dangerous 'minefield'.'


South China Morning Post
17 hours ago
- South China Morning Post
‘Silver Yuan': China's geriatric healthcare a US$134 billion market by 2035, Goldman says
China's geriatric healthcare industry is projected to be worth 963 billion yuan (US$134 billion) over the next decade, as an expanding middle class amid a rapidly ageing population increases the need and willingness to spend, according to a report by Goldman Sachs. Wealthy Chinese consumers were likely to spend three times more than their peers on post-retirement healthcare over the next decade, the US bank said in a report published on Monday, a trend that augurs well for the growth of the so-called silver economy. Consumers with disposable assets of at least 3 million yuan were projected to increase their annual spending on healthcare by 14.3 per cent over the next decade, Goldman said. Spending by this group of wealthy pensioners may balloon fourfold from 221 billion yuan last year. The rise of the so-called silver yuan presents growth opportunities for geriatric healthcare services that were not currently covered in state health insurance policies, such as cataract surgeries, dental implants, vaccines against shingles and the respiratory syncytial virus, according to the report. Medical workers provide free care to the elderly in Liupanshui, southwest China's Guizhou province, October 14, 2021. Photo: Xinhua This group of consumers was also more likely to spend money on early screening, preventive care, and premium treatment such as specialised medications, consumables, higher-quality healthcare services, post-treatment nursing and rehabilitation, the report said.